Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Far East Bio Tec Co's annualized ROCE % for the quarter that ended in Dec. 2025 was 14.08%.
Far East Bio Tec Co (ROCO:6886) ROCE % Explanation
ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.
Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.
Far East Bio Tec Co ROCE % Related Terms
Far East Bio Tec Co ROCE % Historical Data
* Premium members only.
The historical data trend for Far East Bio Tec Co's ROCE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
(1) Note:
The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Far East Bio Tec Co (ROCO:6886) has a ROCE % of 14.08% as of Dec. 2025.
Is Far East Bio Tec Co's ROCE % too high?
Far East Bio Tec Co's current ROCE % is 14.08%. The Consumer Packaged Goods industry median ROCE % is 8.93. Far East Bio Tec Co's value of 14.08% is 57.7% above this industry median. Overall, Far East Bio Tec Co has a GF Score™ of 70/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Far East Bio Tec Co's ROCE % compare to KHC and GIS?
Far East Bio Tec Co's ROCE % of 14.08% can be compared against companies in the Consumer Packaged Goods industry. The industry median ROCE % is 8.93. Far East Bio Tec Co's value of 14.08% is 57.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Consumer Packaged Goods company?
The median ROCE % among Consumer Packaged Goods companies is 8.93, based on 1,943 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Far East Bio Tec Co's current ROCE % of 14.08% is 57.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Consumer Packaged Goods industry, the median ROCE % is 8.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Far East Bio Tec Co's current ROCE % is 14.08%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Far East Bio Tec Co stock overvalued right now?
Based on GuruFocus' analysis, Far East Bio Tec Co (ROCO:6886) is currently considered Fairly Valued. The stock's GF Value™ is NT$48.70, compared to a current price of NT$46.80 — trading 3.9% below its estimated fair value. The current ROCE % is 14.08% and 57.7% above the Consumer Packaged Goods industry median of 8.93. Far East Bio Tec Co's overall GF Score™ is 70/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Far East Bio Tec Co (ROCO:6886), the current ROCE % is 14.08% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Far East Bio Tec Co (ROCO:6886) Overvalued in 2026?
Based on GuruFocus' analysis, Far East Bio Tec Co stock appears to be undervalued.
The current stock price of NT$46.80 is trading 3.9% below its estimated GF Value™ of NT$48.70.
GuruFocus considers Far East Bio Tec Co to be Fairly Valued.
Key valuation signals for ROCO:6886:
ROCE %: 14.08%
GF Value™: NT$48.70 vs. price of NT$46.80 (3.9% below fair value)
Industry Position: 57.7% above the Consumer Packaged Goods median
No single metric tells the full story. See the ROCO:6886 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Far East Bio Tec Co Ltd is a manufacturer of Organic Spirulina, Organic Chlorella, Spirulina natural, and Chlorella natural, nutritional supplements. The firm uses fermentation facilities to produce high-quality nattokinase and spore-forming probiotics. Its products comprise products Organic Spirulina, Organic Chlorella, Chlorella Growth Factor, Phycocyanin, Nattokinase, Lactobacillus sporogenes probiotics, Apogen Microalgae Protein, and DHA Algae Oil. Geographically, the company generates the majority of its revenue from Europe followed by Taiwan.
70GF Score
Get the complete analysis for ROCO:6886
ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6886 has been successfully added to your 
